Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2008
Business Overview: Humana is a full-service benefits solutions company offering health and supplemental benefit products. As of March 31, 2008, the company served approximately 11.4 million medical benefit members and 6.9 million specialty product members. Operations are divided into two segments: Government (Medicare, Military, Medicaid) and Commercial (employer groups and individuals).
Key Financial Metrics
| Metric (in thousands) | Q1 2008 | Q1 2007 |
|---|---|---|
| Total Revenues | $6,959,704 | $6,204,813 |
| Net Income | $80,170 | $71,241 |
| Diluted EPS | $0.47 | $0.42 |
| Operating Cash Flow | $4,439 | $1,574,481 |
| Cash and Equivalents (End of Period) | $1,688,287 | $3,694,059 |
| Long-term Debt | $1,601,335 | $1,687,823 |
| Benefits Ratio (Total) | 86.7% | 86.8% |
| SG&A Expense Ratio (Total) | 13.8% | 13.4% |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 12.2% year-over-year, driven by an 11.8% increase in premium revenues. Government segment premiums rose 10.9% (primarily due to Medicare Advantage growth), while Commercial premiums rose 14.5% (driven by specialty product acquisitions).
- Profitability: Net income increased 12.5% to $80.2 million. The Commercial segment reported income before taxes of $127.2 million (up 34.8%), while the Government segment reported a loss before taxes of $3.2 million, compared to income of $17.9 million in the prior year.
- Cash Flow Volatility: Operating cash flow dropped significantly to $4.4 million from $1.57 billion in Q1 2007. This variance is primarily attributed to the timing of Medicare premium receipts; in Q1 2007, April premiums were received early due to the holiday calendar, whereas Q1 2008 did not include this timing benefit.
- Segment Performance: The Government segment's benefits ratio worsened to 90.0% (from 89.3%) due to higher-than-expected claim expenses in Medicare stand-alone Prescription Drug Plans (PDPs). Conversely, the Commercial segment's benefits ratio improved to 76.8% (from 79.4%) due to underwriting discipline and strategic growth.
Guidance, Outlook, and Risks
- Outlook Revision: Management expects a decrease in consolidated earnings for the full year 2008 compared to 2007 due to lower-than-expected operating results in Medicare stand-alone PDPs. The company anticipates correcting these issues in 2009 bids.
- Membership Growth: The company expects to grow net Medicare Advantage membership by 200,000 to 250,000 members in 2008.
- Acquisitions: Humana signed agreements to acquire the Las Vegas Medicare Advantage business of UnitedHealthGroup (approx. $185 million) and OSF Health Plans (approx. $90.5 million), expected to close in Q2 2008.
- Legal Proceedings: The company is facing three federal securities class actions and two shareholder derivative actions alleging misleading statements regarding Q1 2008 earnings guidance and Medicare Part D costs. Additionally, an ERISA class action has been filed regarding the company's retirement plan. Humana intends to defend these actions vigorously.
- Regulatory Risks: CMS announced audits of Medicare health plans to validate provider coding practices under the risk adjustment model, which could result in material adjustments to premium payments.
Investor Verification Checklist
- Medicare PDP Performance: Verify the specific actuarial variances causing higher claim costs in stand-alone PDPs and the impact on 2009 pricing strategies.
- Legal Exposure: Monitor the status of the securities class actions and ERISA lawsuits filed in Q1 2008 regarding earnings guidance and fiduciary duties.
- Cash Flow Timing: Confirm that the low operating cash flow in Q1 2008 is purely a timing anomaly related to Medicare premium collection dates and not indicative of underlying liquidity issues.
- Acquisition Integration: Assess the integration progress and financial impact of the CompBenefits and KMG acquisitions on Commercial segment margins.
- Debt Management: Review the company's $1.0 billion credit facility utilization and the impact of interest rate swaps on future interest expense.